Grace Ashiru
South Africa-founded healthcare technology startup Healthleap has secured $38 million in seed and Series A funding to expand its artificial intelligence platform designed to help hospitals identify patients at risk of undiagnosed medical conditions.
The funding comprises an $8 million seed round co-led by Sequoia Capital and First Round Capital, alongside a $30 million Series A round led by Hummingbird Ventures.
Founded in 2022 by siblings Jemima and Josiah Meyer, Healthleap develops AI-powered software that examines patients’ electronic medical records to identify warning signs of health conditions that healthcare professionals might otherwise overlook.
The company’s technology analyses clinical notes, laboratory results, vital signs, medication records and other medical information to identify patients who may require additional medical attention.
Healthleap initially focused on detecting malnutrition among hospitalised patients before expanding its technology to identify other conditions, including delirium.
Unlike systems designed to make medical diagnoses, Healthleap’s platform generates risk assessments that help healthcare professionals determine which patients need further evaluation.
According to the company, its technology is already being used in more than 50 hospitals, including Penn Medicine, Cedars-Sinai, Houston Methodist and Emory Healthcare.
The platform integrates with existing hospital electronic health record systems, allowing medical teams to review patient risk information within their normal workflows.
Healthleap says its technology can also help hospitals improve operational efficiency by identifying medical concerns earlier, potentially reducing complications and unnecessary hospital stays.
The company reported significant growth in hospital partnerships over the past year, reflecting increasing interest in artificial intelligence applications within healthcare.
Healthleap plans to use the newly secured capital to expand its engineering, product development, sales and customer support teams.
The startup also intends to broaden its technology to identify more than 40 major medical conditions, with longer-term ambitions to expand into outpatient and home-based healthcare.
The investment highlights growing investor interest in AI-powered healthcare solutions that support clinical decision-making and address challenges faced by overstretched medical professionals.
For Africa’s technology ecosystem, Healthleap’s growth also demonstrates the potential for startups founded on the continent to develop healthcare innovations capable of serving international markets.
